Patient-Reported Quality of Life in Patients with an Implantable-Cardioverter Defibrillator - a Longitudinal Observational Study

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Oct 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how having an implantable cardioverter-defibrillator (ICD) affects patients' quality of life over time. An ICD is a device that helps prevent life-threatening heart rhythms and has been shown to improve survival for those at risk. However, living with this device can come with challenges that may impact how patients feel physically and emotionally. The study aims to gather information about how patients' quality of life changes after they receive an ICD, focusing on their overall health, how they accept the device, and any concerns they may have about physical activity and intimacy.

To participate in this trial, individuals must be at least 18 years old and either scheduled for a new ICD implantation or for a generator change of an existing ICD. Participants should also be able to give their written consent to join the study. Unfortunately, those with mental disabilities will not be eligible. While the study is not yet recruiting, it will provide valuable insights into the experiences of ICD patients, helping healthcare professionals better support them in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years of age
• • Patients either scheduled for a new ICD implantation or scheduled for an elective generator change
• • Willing and able to provide signed written informed consent.
• Exclusion Criteria:
• • Patients with a mental disability